Invention Grant
- Patent Title: Room temperature stable oral calcitonin formulation
-
Application No.: US17675643Application Date: 2022-02-18
-
Publication No.: US11998640B2Publication Date: 2024-06-04
- Inventor: James P. Gilligan , George R. Maurer , Aniruddha M. Railkar , Phillip Bauer , Thomas A. Daggs , Paul P. Shields
- Applicant: PARK THERAPEUTICS, INC. , ENTERIS BIOPHARMA, INC
- Applicant Address: US NJ Monmouth Junction
- Assignee: Park Therapeutics, Inc.,Enteris Biopharma, Inc.
- Current Assignee: Park Therapeutics, Inc.,Enteris Biopharma, Inc.
- Current Assignee Address: US NJ Monmouth Junction; US NJ Boonton
- Agency: HALEY GUILIANO LLP
- Agent James F. Haley, Jr.; Brian M. Gummow
- The original application number of the division: US16267902 2019.02.05
- Main IPC: A61K9/28
- IPC: A61K9/28 ; A61K9/20 ; A61K38/23 ; A61P19/02 ; A61P19/10

Abstract:
Room-temperature stable dosage forms for oral delivery of calcitonin are disclosed herein. Dosage forms for oral delivery of calcitonin with low water content are also disclosed herein. Further disclosed herein are methods for producing such room-temperature stable dosage forms and low-water content dosage forms. Methods of treatment comprising the administration of such room-temperature stable dosage forms and low-water content dosage forms are also disclosed herein.
Public/Granted literature
- US20230000779A1 ROOM TEMPERATURE STABLE ORAL CALCITONIN FORMULATION Public/Granted day:2023-01-05
Information query